143 related articles for article (PubMed ID: 17249271)
1. The essentials of locoregional control in the treatment of gastric cancer.
den Dulk M; Verheij M; Cats A; Jansen EP; Hartgrink HH; Van de Velde CJ
Scand J Surg; 2006; 95(4):236-42. PubMed ID: 17249271
[TBL] [Abstract][Full Text] [Related]
2. Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer?
Jansen EP; Boot H; van de Velde CJ; van Sandick J; Cats A; Verheij M
Recent Results Cancer Res; 2012; 196():229-40. PubMed ID: 23129378
[TBL] [Abstract][Full Text] [Related]
3. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
[TBL] [Abstract][Full Text] [Related]
4. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
5. [Postoperative adjuvant chemoradiotherapy in high risk stomach carcinoma].
Shah MA; Kelsen DP
Chirurg; 2002 Apr; 73(4):325-30. PubMed ID: 12063916
[TBL] [Abstract][Full Text] [Related]
6. Perioperative chemotherapy for resectable gastric cancer - what is the evidence?
Bringeland EA; Wasmuth HH; Grønbech JE
Scand J Gastroenterol; 2017; 52(6-7):647-653. PubMed ID: 28276825
[TBL] [Abstract][Full Text] [Related]
7. Selecting the best treatment for an individual patient.
Bittoni A; Faloppi L; Giampieri R; Cascinu S
Recent Results Cancer Res; 2012; 196():307-18. PubMed ID: 23129382
[TBL] [Abstract][Full Text] [Related]
8. Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial.
Claassen YHM; de Steur WO; Hartgrink HH; Dikken JL; van Sandick JW; van Grieken NCT; Cats A; Trip AK; Jansen EPM; Kranenbarg WMM; Braak JPBM; Putter H; van Berge Henegouwen MI; Verheij M; van de Velde CJH
Ann Surg; 2018 Dec; 268(6):1008-1013. PubMed ID: 28817437
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant and neoadjuvant approaches in gastric cancer.
Ng K; Meyerhardt JA; Fuchs CS
Cancer J; 2007; 13(3):168-74. PubMed ID: 17620766
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemoradiotherapy in gastric cancer and carcinoma of the oesophago-gastric junction.
Stahl M
Onkologie; 2004 Feb; 27(1):33-6. PubMed ID: 15007246
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
12. Expanding treatment options for resectable gastric cancer: Is it a countdown for radiotherapy?
Hizal M; Sendur MA; Bilgin B; Bulent Akinci M; Sener Dede D; Yalcin B
J BUON; 2019; 24(4):1367-1370. PubMed ID: 31646779
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of and therapy for gastric cancer--work-flow].
Grundmann RT; Hölscher AH; Bembenek A; Bollschweiler E; Drognitz O; Feuerbach S; Gastinger I; Hermanek P; Hopt UT; Hünerbein M; Illerhaus G; Junginger T; Kraus M; Meining A; Merkel S; Meyer HJ; Mönig SP; Piso P; Roder J; Rödel C; Tannapfel A; Wittekind C; Woeste G
Zentralbl Chir; 2009 Aug; 134(4):362-74. PubMed ID: 19688686
[TBL] [Abstract][Full Text] [Related]
14. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
[TBL] [Abstract][Full Text] [Related]
15. Combined-modality therapy for gastric cancer.
Yao JC; Mansfield PF; Pisters PW; Feig BW; Janjan NA; Crane C; Ajani JA
Semin Surg Oncol; 2003; 21(4):223-7. PubMed ID: 14648779
[TBL] [Abstract][Full Text] [Related]
16. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer.
Moehler M; Galle PR; Gockel I; Junginger T; Schmidberger H
Best Pract Res Clin Gastroenterol; 2007; 21(6):965-81. PubMed ID: 18070698
[TBL] [Abstract][Full Text] [Related]
17. Resected gastric cancer with D2 dissection: advances in adjuvant chemoradiotherapy and radiotherapy techniques.
Wu Q; Li G; Xu F
Expert Rev Anticancer Ther; 2015 Jun; 15(6):703-13. PubMed ID: 26004039
[TBL] [Abstract][Full Text] [Related]
18. Optimal locoregional treatment in gastric cancer.
Jansen EP; Boot H; Verheij M; van de Velde CJ
J Clin Oncol; 2005 Jul; 23(20):4509-17. PubMed ID: 16002841
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
20. Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial.
Claassen YHM; Hartgrink HH; de Steur WO; Dikken JL; van Sandick JW; van Grieken NCT; Cats A; Trip AK; Jansen EPM; Kranenbarg WMM; Braak JPBM; Putter H; van Berge Henegouwen MI; Verheij M; van de Velde CJH
Gastric Cancer; 2019 Mar; 22(2):369-376. PubMed ID: 30238171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
